ALBHF (Alibaba Health Information Technology) LT-Debt-to-Total-Asset: 0.00 (As of Mar. 2026)


ALBHF Alibaba Health Information Technology Ltd ALBHF
55 GF Score
Price $0.41
GF Value $0.65
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology LT-Debt-to-Total-Asset?

Alibaba Health Information Technology ALBHF -2.64% 55 LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus rates ALBHF with a GF Score™ of 55/100 and a GF Value™ of $0.65 (Significantly Undervalued). The stock has 2 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Alibaba Health Information Technology's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.00.

Alibaba Health Information Technology's long-term debt to total assets ratio stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00).

Alibaba Health Information Technology  (OTCPK:ALBHF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Alibaba Health Information Technology LT-Debt-to-Total-Asset Related Terms

Alibaba Health Information Technology LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Alibaba Health Information Technology's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology LT-Debt-to-Total-Asset Chart

Alibaba Health Information Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Alibaba Health Information Technology Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ALBHF
55GF Score
Alibaba Health Information Technology Ltd ALBHF
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alibaba Health Information Technology LT-Debt-to-Total-Asset Calculation

Alibaba Health Information Technology's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )/Total Assets (A: Mar. 2026 )
=4.378/3350.663
=0.00

Alibaba Health Information Technology's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=4.378/3350.663
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Alibaba Health Information Technology (ALBHF) has a LT-Debt-to-Total-Asset of 0.00 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Alibaba Health Information Technology and its competitors.
Is Alibaba Health Information Technology's LT-Debt-to-Total-Asset too high?
Alibaba Health Information Technology's current LT-Debt-to-Total-Asset is 0.00. Overall, Alibaba Health Information Technology has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's LT-Debt-to-Total-Asset compare to competitors?
Alibaba Health Information Technology's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Healthcare Providers & Services company?
A good LT-Debt-to-Total-Asset depends on the Healthcare Providers & Services industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Alibaba Health Information Technology and its competitors. Alibaba Health Information Technology's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.65, compared to a current price of $0.41 — trading 36.9% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Alibaba Health Information Technology's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of $0.41 is trading 36.9% below its estimated GF Value™ of $0.65. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for ALBHF:

  • LT-Debt-to-Total-Asset: 0.00
  • GF Value™: $0.65 vs. price of $0.41 (36.9% below fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alibaba Health Information Technology Business Description

Address Wangjing East Park, 30th Floor, Greenland Center, Building 9, Zone 4, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
55GF Score

Get the complete analysis for ALBHF

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.41
Price
$0.65
GF Value